A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment
- 28 February 2011
- journal article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 12 (2), 137-143
- https://doi.org/10.1016/s1470-2045(10)70296-5
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Statistical consideration for clinical biomarker research in bladder cancerUrologic Oncology, 2010
- Combined Gene Expression and Genomic Profiling Define Two Intrinsic Molecular Subtypes of Urothelial Carcinoma and Gene Signatures for Molecular Grading and OutcomeCancer Research, 2010
- The COXEN Principle: Translating Signatures of In vitro Chemosensitivity into Tools for Clinical Outcome Prediction and Drug Discovery in CancerCancer Research, 2010
- Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancerMolecular Cancer, 2010
- Bladder Cancer: Narrowing the Gap Between Evidence and PracticeJournal of Clinical Oncology, 2009
- Concordant Gene Expression Signatures Predict Clinical Outcomes of Cancer Patients Undergoing Systemic TherapyCancer Research, 2009
- Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissuesBMC Genomics, 2009
- A strategy for predicting the chemosensitivity of human cancers and its application to drug discoveryProceedings of the National Academy of Sciences of the United States of America, 2007
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerThe New England Journal of Medicine, 2004
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerThe New England Journal of Medicine, 2003